Description:
A novel non-nucleoside reverse transcriptase inhibitor. Rilpivirine seems to be well tolerated with less CNS disturbance than Efavirenz, and has non-teratogenic potential. An anti-HIV agent.
- Molecular Weight: 366.428
- Molecular Formula: C22H18N6
Purity: 98%
Canonical SMILES:
CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N
InChI:
InChI=1S/C22H18N6/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19/h3-9,11-13H,1-2H3,(H2,25,26,27,28)/b4-3+
InChIKey: YIBOMRUWOWDFLG-ONEGZZNKSA-N
- Boiling Point: 634.1±65.0 °C at 760 mmHg
- Melting Point: 245°C
- Solubility: In vitro: 10 mM in DMSO
- Appearance: Light yellow to yellow (Solid)
- Storage: Powder: -20°C: 3 years; 4°C: 2 years; In solvent: -80°C: 6 months; -20°C: 1 month
Synonyms:
R 278474; TMC 278; R-278474; R278474; TMC278; TMC-278
More details are to be found on supplier website
